Last 63.35 INR
Change Today 0.00 / 0.00%
Volume 0.0
OCP On Other Exchanges
Symbol
Exchange
London
As of 6:06 AM 02/28/15 All times are local (Market data is delayed by at least 15 minutes).

orchid chemicals & pharma (OCP) Snapshot

Open
64.50
Previous Close
64.15
Day High
64.75
Day Low
63.00
52 Week High
07/15/14 - 85.45
52 Week Low
03/4/14 - 44.00
Market Cap
5.4B
Average Volume 10 Days
852.4K
EPS TTM
--
Shares Outstanding
85.3M
EX-Date
09/13/12
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORCHID CHEMICALS & PHARMA (OCP)

Related News

No related news articles were found.

orchid chemicals & pharma (OCP) Related Businessweek News

No Related Businessweek News Found

orchid chemicals & pharma (OCP) Details

Orchid Chemicals & Pharmaceuticals Limited, an integrated pharmaceutical company, is engaged in the research, development, manufacture, marketing, and export of active pharmaceutical ingredients (APIs) and finished dosage forms worldwide. Its API product portfolio includes oral cephalosporins, injectable cephalosporins, carbapenems, non-antibiotics, penicillins, and veterinary products. The company also offers anti-infectives, anti-inflammatory, central nervous system, cardio vascular system, nutraceutical, other oral and sterile products, anti-diabetic formulations, and neuropsychiatry system formulations, as well as nutritional supplements. In addition, it provides new drug discovery, novel drug delivery systems, and contract research and manufacturing services. Orchid Chemicals & Pharmaceuticals Limited was founded in 1992 and is headquartered in Chennai, India.

4,455 Employees
Last Reported Date: 08/27/12
Founded in 1992

orchid chemicals & pharma (OCP) Top Compensated Officers

Managing Director, Executive Director, Chairm...
Total Annual Compensation: 74.2M
Compensation as of Fiscal Year 2013.

orchid chemicals & pharma (OCP) Key Developments

Orchid Chemicals & Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the Three Months and Fifteen Months Ended December 31, 2014

Orchid Chemicals & Pharmaceuticals Limited reported unaudited standalone earnings results for the three months and fifteen months ended December 31, 2014. For the three months period, the company reported total operating income of INR 1,645.352 million compared to INR 3,716.005 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 171.944 million compared to profit from operations before other income, finance costs and exceptional items of INR 520.845 million a year ago. Loss from ordinary activates before tax was INR 1,440.506 million compared to INR 539.024 million a year ago. Net loss was INR 1,200.943 million or INR 14.09 per basic and diluted share before and after extra ordinary items (not annualized) compared to INR 539.024 million or INR 7.65 per basic and diluted share before and after extra ordinary items (not annualized) a year ago. For the fifteen months period, the company reported total operating income of INR 14,489.478 million, profit from operations before other income, finance costs and exceptional items of INR 133.370 million, loss from ordinary activates before tax of INR 4,746.971 million and net loss of INR 429.904 million or INR 5.04 per basic and diluted per share before and after extra ordinary items.

Orchid Chemicals & Pharmaceuticals Limited to Report Q3, 2015 Results on Feb 13, 2015

Orchid Chemicals & Pharmaceuticals Limited announced that they will report Q3, 2015 results on Feb 13, 2015

Orchid Chemicals & Pharmaceuticals Limited, Board Meeting, Feb 13, 2015

Orchid Chemicals & Pharmaceuticals Limited, Board Meeting, Feb 13, 2015. Agenda: To take on record the unaudited financial results for the period from October 01, 2014 to December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCP:IN 63.35 INR 0.00

OCP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CF Industries Holdings Inc $306.23 USD -0.38
PhosAgro OAO 2,109 RUB +19.00
Potash Corp of Saskatchewan Inc C$44.85 CAD +0.26
Saudi Arabian Mining Co SR41.80 SAR -0.87
Mosaic Co/The $53.26 USD +0.06
View Industry Companies
 

Industry Analysis

OCP

Industry Average

Valuation OCP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORCHID CHEMICALS & PHARMA, please visit www.orchidpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.